more
Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot
This article reviews antisense and gene therapy strategies for DMD mutations in the exon 2–22 region, focusing on exon skipping, AAV vectors, and microdystrophin therapy.
